Search

Your search keyword '"Capra, William"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Capra, William" Remove constraint Author: "Capra, William"
31 results on '"Capra, William"'

Search Results

1. Augmenting control arms with Real-World Data for cancer trials: Hybrid control arm methods and considerations

5. P1244: AN AUTOMATED QUANTIFICATION ALGORITHM FOR EVALUATING TOTAL METABOLIC TUMOR VOLUME IN PATIENTS WITH FDG-AVID LYMPHOMAS USING A DEEP LEARNING MODEL

10. Development and Validation of a High-Quality Composite Real-World Mortality Endpoint

12. Emulating Control Arms for Cancer Clinical Trials Using External Cohorts Created From Electronic Health Record‐Derived Real‐World Data

13. Comparing phase 3 “go” decisions (Ph3-GO) between single arm trials with real-world external control (SAT+rwEC) versus randomized phase 2 trials (rPh2).

17. Rates of Mortality in Populations of Caenorhabditis elegans

18. Emulating Control Arms for Cancer Clinical Trials Using External Cohorts Created From Electronic Health Record‐Derived Real‐World Data.

21. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure

22. Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set

24. An evaluation of the impact of missing deaths on overall survival analyses of advanced non–small cell lung cancer patients conducted in an electronic health records database

25. Using Electronic Health Records to Derive Control Arms for Early Phase Single‐Arm Lung Cancer Trials: Proof‐of‐Concept in Randomized Controlled Trials.

28. A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors

30. Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count >= 300 cells/mu L who were assigned to 7.5 MIU interleukin-2

31. Pooled Analysis of 3 Randomized, Controlled Trials of Interleukin-2 Therapy in Adult Human Immunodeficiency Virus Type 1 Disease.

Catalog

Books, media, physical & digital resources